An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

Oncogene

Volumn 31, Issue 16, 2012, Pages 2090-2100

  Mamo, A ^a   Cavallone, L ^b   Tuzmen, S ^c   Chabot, C ^a   Ferrario, C ^a   Hassan, S ^a   Edgren, H ^d,e   Kallioniemi, O ^d,e   Aleynikova, O ^a   Przybytkowski, E ^a   Malcolm, K ^a   Mousses, S ^c   Tonin, P N ^b,f   Basik, M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

ARID1A; breast cancer; nonsense mediated mRNA decay; tumor suppressor gene

Indexed keywords

ARID1A PROTEIN; PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; EXON; GENE DOSAGE; GENE MUTATION; GENE TARGETING; GENOME; HUMAN; HUMAN CELL; NONSENSE MEDIATED MRNA DECAY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOP CODON; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 1; CODON, NONSENSE; DNA COPY NUMBER VARIATIONS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; RNA; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84859899141     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.386     Document Type: Article

References (50)

1. Adler HT, Chinery R, Wu DY, Kussick SJ, Payne JM, Fornace Jr AJ et al. (1999). Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol 19: 7050-7060. (Pubitemid 29441887)
2. Belandia B, Orford RL, Hurst HC, Parker MG. (2002). Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J 21: 4094-4103. (Pubitemid 34857441)
3. Berx G, van Roy F. (2009). Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1: a003129.
4. Biegel JA, Pollack IF. (2004). Molecular analysis of pediatric brain tumors. Curr Oncol Rep 6: 445-452. (Pubitemid 39585690)
5. Campeau PM, Foulkes WD, Tischkowitz MD. (2008). Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124: 31-42.
6. Carlson M, Laurent BC. (1994). The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol 6: 396-402. (Pubitemid 24170011)
7. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG et al. (2005). Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
8. Dallas PB, Cheney IW, Liao DW, Bowrin V, Byam W, Pacchione S et al. (1998). p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes.Mol Cell Biol 18: 3596-3603. (Pubitemid 28240532)
9. Dallas PB, Pacchione S, Wilsker D, Bowrin V, Kobayashi R, Moran E. (2000). The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol Cell Biol 20: 3137-3146. (Pubitemid 30215026)
10. Dworkin AM, Huang TH, Toland AE. (2009). Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 19: 165-171.
11. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C et al. (2010). COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38: D652-D657.
12. Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NC. (1999). Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res 59: 3870-3874. (Pubitemid 29393542)
13. Hassan S, Baccarelli A, Salvucci O, Basik M. (2008). Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 14: 446-454. (Pubitemid 351226112)
14. Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A et al. (2009). The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer. Am J Pathol 175: 66-73.
15. Hirschhorn JN, Bortvin AL, Ricupero-Hovasse SL,Winston F. (1995). A new class of histone H2A mutations in Saccharomyces cerevisiae causes specific transcriptional defects in vivo.Mol Cell Biol 15: 1999-2009.
16. Hosein AN, Wu M, Arcand SL, Lavallee S, Hebert J, Tonin PN et al. (2010). Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. Cancer Res 70: 5770-5777.
17. Huang J, Zhao YL, Li Y, Fletcher JA, Xiao S. (2007). Genomic and functional evidence for an ARID1A tumor suppressor role. Genes Chromosomes Cancer 46: 745-750. (Pubitemid 46912345)
18. Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S et al. (2004). Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet 36: 979-983. (Pubitemid 39167494)
19. Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, Roden R et al. (2010). Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330: 228-231.
20. Kennison JA. (1995). The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 29: 289-303.
21. Li XS, Trojer P, Matsumura T, Treisman JE, Tanese N. (2010). Mammalian SWI/SNF - a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.Mol Cell Biol 30: 1673-1688.
22. Medina PP, Sanchez-Cespedes M. (2008). Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Epigenetics 3: 64-68.
23. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550-13555. (Pubitemid 41420886)
24. Nagl Jr NG, Patsialou A, Haines DS, Dallas PB, Beck Jr GR, Moran E. (2005). The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest. Cancer Res 65: 9236-9244. (Pubitemid 41507989)
25. Nagl Jr NG, Wang X, Patsialou A, Van Scoy M, Moran E. (2007). Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 26: 752-763.
26. Nagl Jr NG, Zweitzig DR, Thimmapaya B, Beck Jr GR, Moran E. (2006). The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res 66: 1289-1293. (Pubitemid 43259906)
27. Noensie EN, Dietz HC. (2001). A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol 19: 434-439. (Pubitemid 32428285)
28. Orlando FA, Brown KD. (2009). Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis. Ann Surg Oncol 16: 2270-2279.
29. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T et al. (2009). Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27: 1160-1167.
30. Patsialou A, Wilsker D, Moran E. (2005). DNA-binding properties of ARID family proteins. Nucleic Acids Res 33: 66-80. (Pubitemid 40276929)
31. Presneau N, Manderson EN, Tonin PN. (2003). The quest for a tumor suppressor gene phenotype. Curr Mol Med 3: 605-629. (Pubitemid 37236404)
32. Roberts CW, Biegel JA. (2009). The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 8: 412-416.
33. Rodriguez-Nieto S, Sanchez-Cespedes M. (2009). BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. Carcinogenesis 30: 547-554.
34. Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J et al. (1998). The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci USA 95: 4152-4157. (Pubitemid 28207880)
35. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274. (Pubitemid 44571966)
36. Staden R, Beal KF, Bonfield JK. (2000). The Staden package, 1998. Methods Mol Biol 132: 115-130.
37. Strumane K, Berx G, Van Roy F. (2004). Cadherins in cancer. Handb Exp Pharmacol 165: 69-103.
38. Sudarsanam P, Cao Y, Wu L, Laurent BC, Winston F. (1999). The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with the histone acetyltransferase, Gcn5. EMBO J 18: 3101-3106. (Pubitemid 29255618)
39. Sudarsanam P, Iyer VR, Brown PO, Winston F. (2000). Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 97: 3364-3369. (Pubitemid 30183308)
40. Takeuchi T, Chen BK, Qiu Y, Sonobe H, Ohtsuki Y. (1997). Molecular cloning and expression of a novel human cDNA containing CAG repeats. Gene 204: 71-77. (Pubitemid 28022172)
41. Takeuchi T, Furihata M, Heng HH, Sonobe H, Ohtsuki Y. (1998). Chromosomal mapping and expression of the human B120 gene. Gene 213: 189-193. (Pubitemid 28284738)
42. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M et al. (1997). Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 16: 5310-5321. (Pubitemid 27380139)
43. Van Rechem C, Boulay G, Leprince D. (2009). HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. Biochem Biophys Res Commun 385: 586-590.
44. Vogelstein B, Kinzler KW. (2004). Cancer genes and the pathways they control. Nat Med 10: 789-799. (Pubitemid 39070849)
45. Wang X, Nagl NG, Wilsker D, Van Scoy M, Pacchione S, Yaciuk P et al. (2004). Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. Biochem J 383: 319-325. (Pubitemid 39446693)
46. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T et al. (2010). ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532-1543.
47. Wilsker D, Patsialou A, Zumbrun SD, Kim S, Chen Y, Dallas PB et al. (2004). The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexes. Nucleic Acids Res 32: 1345-1353. (Pubitemid 38864679)
48. Winston F, Carlson M. (1992). Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet 8: 387-391.
49. Yuge M, Nagai H, Uchida T, Murate T, Hayashi Y, Hotta T et al. (2000). HSNF5/INI1 gene mutations in lymphoid malignancy. Cancer Genet Cytogenet 122: 37-42.
50. Zhang B, Chambers KJ, Faller DV, Wang S. (2007). Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation. Oncogene 26: 7153-7157. (Pubitemid 350059673)